TrialBMC musculoskeletal disorders2021

Open-label phase 3 study of diclofenac conjugated to hyaluronate (diclofenac etalhyaluronate: ONO-5704/SI-613) for treatment of osteoarthritis: 1-year follow-up.

Yoshihiro Nishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.